Li Mingzhu, Jiang Yeqian, Xu Ying, Li Qianbing
Department of Respiratory and Critical Care Medicine, Anqing First People's Hospital of Anhui Medical University, 42 Xiaosu Road, Yingjiang District, Anqing, 246003, China.
The Fifth Clinical College of Anhui Medical University, Hefei, China.
Thromb J. 2025 Apr 29;23(1):42. doi: 10.1186/s12959-025-00728-6.
An increased prevalence of PE has been found in patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD). Early identification of risk factors for the development of PE in patients with AECOPD and intervention is important. Therefore, we comprehensively pool and analyze the prevalence and risk factors of PE among patients experiencing AECOPD, aiming to provide valuable insights for clinical-based diagnostic determination and prevention of PE in the AECOPD patient population.
A systematic literature search was conducted for studies reporting the incidence and risk factors for PE in patients with AECOPD. Study quality was assessed using the modified Newcastle-Ottawa Quality Assessment Scale. The degree of heterogeneity was assessed by the I statistic. The publication bias (studies ≥ 10) was evaluated using Egger's test.
Among the 1421 studies initially retrieved, 22 articles were ultimately selected and incorporated into the analysis. Based on the meta-analysis and the review's updated findings, the prevalence of PE in AECOPD is 17.82% (95% CI 12.72%-23.57%, P<0.001). The following factors were identified as risk factors for PE among patients with AECOPD: age(weighted mean difference [WMD] 2.0119, 95% CI 0.7126-3.3133, I = 51.8%, P = 0.02), males(odds ratio [OR] 0.9528, 95% CI 0.6869-1.3216, I = 65.0%, P<0.001), obesity(OR 1.3086, 95% CI 0.1895-9.0385, I = 74.5%, P = 0.02), malignant disease(OR 1.5902, 95%CI 0.9689-2.6097, I = 54.7%, P = 0.03), hypertension(OR 1.0663, 95%CI 0.7920-1.4355, I = 57.7%, P = 0.009), immobilization ≥ 3d(OR 3.9158, 95% CI 1.0925-14.0354, I = 91.6%, P<0.001), edema of lower limb(OR 2.1558, 95% CI 1.3365-3.4773, I = 75.4%, P<0.001), pulmonary hypertension(OR 1.3146, 95%CI 0.7481-2.3100, I = 70.1%, P = 0.04), cough(OR 0.7084, 95%CI 0.1304-3.8497, I = 88.8%, P<0.001), purulent sputum(OR 0.7570, 95%CI 0.4005-1.4309, I = 61.9%, P = 0.049), and D-dimer(WMD 0.8619, 95%CI 0.0449-1.6789, I = 91.4%, P<0.001), C-reactive protein(CRP)(WMD 0.8852, 95%CI -4.0639-5.8344, I = 76.4%, P = 0.005) or fibrinogen(WMD 0.8663, 95%CI -0.2572-1.9898, I = 92.2%, P<0.001) levels. Clinical risk factors(including S1Q3 pattern on electrocardiograph(ECG), hospital stay and home oxygen therapy) showed no significant association with the occurrence of PE (P>0.05).
This updated meta-analysis and systematic review revealed that the prevalence of pulmonary embolism in the AECOPD was 17.82%. This figure may vary depending on how the diagnostic procedure is carried out. Age, males, obesity, malignant disease, hypertension, immobilization ≥ 3d, edema of lower limb, pulmonary hypertension, cough, purulent sputum, and D-dimer, CRP or fibrinogen level may serve as potential risk factors for PE among patients with AECOPD.
慢性阻塞性肺疾病急性加重期(AECOPD)患者中肺栓塞(PE)的患病率有所增加。早期识别AECOPD患者发生PE的危险因素并进行干预很重要。因此,我们全面汇总并分析了AECOPD患者中PE的患病率及危险因素,旨在为基于临床的AECOPD患者群体PE诊断判定和预防提供有价值的见解。
对报告AECOPD患者PE发病率和危险因素的研究进行系统文献检索。使用改良的纽卡斯尔-渥太华质量评估量表评估研究质量。用I统计量评估异质性程度。使用Egger检验评估发表偏倚(研究≥10项)。
在最初检索的1421项研究中,最终选择了22篇文章纳入分析。基于荟萃分析和综述的最新结果,AECOPD患者中PE的患病率为17.82%(95%可信区间12.72%-23.57%,P<0.001)。以下因素被确定为AECOPD患者发生PE的危险因素:年龄(加权均数差[WMD]2.0119,95%可信区间0.7126-3.3133,I=51.8%,P=0.02)、男性(比值比[OR]0.9528,95%可信区间0.6869-1.3216,I=65.0%,P<0.001)、肥胖(OR 1.3086,95%可信区间0.1895-9.0385,I=74.5%,P=0.02)、恶性疾病(OR 1.5902,95%可信区间0.9689-2.6097,I=54.7%,P=0.03)、高血压(OR 1.0663,95%可信区间0.7920-1.4355,I=57.7%,P=0.009)、制动≥3天(OR 3.9158,95%可信区间1.0925-14.0354,I=91.6%,P<0.001)、下肢水肿(OR 2.1558,95%可信区间1.3365-3.4773,I=75.4%,P<0.001)、肺动脉高压(OR 1.3146,95%可信区间0.7481-2.3100,I=70.1%,P=0.04)、咳嗽(OR 0.7084,95%可信区间0.1304-3.8497,I=88.8%,P<0.001)、脓性痰(OR 0.7570,95%可信区间0.4005-1.4309,I=61.9%,P=0.049)以及D-二聚体(WMD 0.8619,95%可信区间0.0449-1.6789,I=91.4%,P<0.001)、C反应蛋白(CRP)(WMD 0.8852,95%可信区间-4.0639-5.8344,I=76.4%,P=0.005)或纤维蛋白原(WMD 0.8663,95%可信区间-0.2572-1.9898,I=92.2%,P<0.001)水平。临床危险因素(包括心电图[ECG]上的S1Q3型、住院时间和家庭氧疗)与PE的发生无显著关联(P>0.05)。
这项更新的荟萃分析和系统评价显示,AECOPD患者中肺栓塞的患病率为17.82%。该数字可能因诊断程序的实施方式而异。年龄、男性、肥胖、恶性疾病、高血压、制动≥3天、下肢水肿、肺动脉高压、咳嗽、脓性痰以及D-二聚体、CRP或纤维蛋白原水平可能是AECOPD患者发生PE的潜在危险因素。